Free Trial

Genus (LON:GNS) Shares Pass Above Two Hundred Day Moving Average - Should You Sell?

Genus logo with Medical background

Shares of Genus plc (LON:GNS - Get Free Report) crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 1,839.42 ($23.67) and traded as high as GBX 1,904 ($24.50). Genus shares last traded at GBX 1,810 ($23.29), with a volume of 77,521 shares.

Wall Street Analysts Forecast Growth

Separately, Deutsche Bank Aktiengesellschaft cut their price objective on shares of Genus from GBX 2,300 ($29.60) to GBX 2,150 ($27.67) and set a "buy" rating for the company in a research report on Wednesday, July 17th.

Read Our Latest Research Report on Genus

Genus Stock Down 1.9 %

The firm's 50 day simple moving average is GBX 1,972.76 and its two-hundred day simple moving average is GBX 1,839.83. The firm has a market cap of £1.16 billion, a price-to-earnings ratio of 15,116.67, a PEG ratio of 2.87 and a beta of 0.37. The company has a current ratio of 1.80, a quick ratio of 1.08 and a debt-to-equity ratio of 53.54.

Genus Increases Dividend

The company also recently disclosed a dividend, which will be paid on Friday, December 6th. Shareholders of record on Thursday, November 7th will be paid a dividend of GBX 21.70 ($0.28) per share. This represents a yield of 1.21%. This is an increase from Genus's previous dividend of $10.30. The ex-dividend date of this dividend is Thursday, November 7th. Genus's dividend payout ratio is presently 26,666.67%.

Insider Buying and Selling at Genus

In related news, insider Jorgen Kokke sold 2,186 shares of Genus stock in a transaction that occurred on Monday, September 16th. The shares were sold at an average price of GBX 1,956 ($25.17), for a total transaction of £42,758.16 ($55,022.73). In other Genus news, insider Iain Ferguson purchased 3,000 shares of the company's stock in a transaction dated Thursday, September 5th. The stock was purchased at an average price of GBX 1,800 ($23.16) per share, with a total value of £54,000 ($69,489.13). Also, insider Jorgen Kokke sold 2,186 shares of Genus stock in a transaction on Monday, September 16th. The stock was sold at an average price of GBX 1,956 ($25.17), for a total transaction of £42,758.16 ($55,022.73). Company insiders own 0.75% of the company's stock.

About Genus

(Get Free Report)

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.

Featured Stories

Should you invest $1,000 in Genus right now?

Before you consider Genus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genus wasn't on the list.

While Genus currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?
Rocket Lab Stock Explodes Higher—What’s Next for This Space Pioneer?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines